OOIR: Observatory of International Research

Papers

(The TQCC of Expert Review of Proteomics is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Multiomic analysis of cytokines in immuno-oncology	101
Top-down proteomics: challenges, innovations, and applications in basic and clinical research	70
Network-based strategies in metabolomics data analysis and interpretation: from molecular networking to biological interpretation	70
Analytical techniques for multiplex analysis of protein biomarkers	58
Design of engineered surfaces for prospective detection of SARS-CoV-2 using quartz crystal microbalance-based techniques	40
The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications	39
Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications	35
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective	27
Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research	25
Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study	23
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic	23
Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade	22
Molecular markers for cervical cancer screening	21
Salivary metabolomics for cancer detection	21
Mass spectrometry-based metabolomics diagnostics – myth or reality?	20
A complete proteomic profile of human and bovine milk exosomes by liquid chromatography mass spectrometry	20
On the potential of micro-flow LC-MS/MS in proteomics	20
Studies in lung cancer cytokine proteomics: a review	19
Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine	19
De novo sequencing of proteins by mass spectrometry	18
Surveying over 100 predictors of intrinsic disorder in proteins	18
The potential for metabolomics in the study and treatment of major depressive disorder and related conditions	17
Proteomic studies of common chronic pain conditions - a systematic review and associated network analyses	17
Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells	16
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases	16

Skin proteomics – analysis of the extracellular matrix in health and disease	16
Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm	16
Advances in the proteomic profiling of the matrisome and adhesome	16
Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical application	15
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants	15
The application of proteomics in muscle exercise physiology	14
Replication of single-cell proteomics data reveals important computational challenges	14
Update on Proteomic approaches to uncovering virus-induced protein alterations and virus –host protein interactions during the progression of viral infection	14
Proteomics and plant biology: contributions to date and a look towards the next decade	14
Protein lysine acetylation and its role in different human pathologies: a proteomic approach	13
Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside	13
An overview of technologies for MS-based proteomics-centric multi-omics	12
Lipid droplets diversity and functions in inflammation and immune response	12
The role of proteomics in defining autoimmunity	12
New insights into human prefrontal cortex aging with a lipidomics approach	12
Targeted urine proteomics in lupus nephritis – a meta-analysis	12
Mass spectrometry in the lipid study of cancer	12
Characterization of tick salivary gland and saliva alphagalactome reveals candidate alpha-gal syndrome disease biomarkers	12
The phosphoinositide code is read by a plethora of protein domains	12
Kidney stone proteomics: an update and perspectives	12
Protein amino-termini and how to identify them	11
The clinical potential of prm-PASEF mass spectrometry	11
Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle	11
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics	11
Early disease biomarkers can be found using animal models urine proteomics	11
Mass Spectrometry-based Biomarkers for Knee Osteoarthritis: A Systematic Review	10
Mass spectrometry-based phospholipid imaging: methods and findings	10
Deep learning approaches for data-independent acquisition proteomics	10